SCHEMBL5054065

SCHEMBL5054065

C=CC(O)C(O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ADRA2A P08913 1/20 0.46
LMNA P02545 1/20 0.46
HIF1A Q16665 1/20 0.46
ALDH1A1 P00352 4/20 0.45
AOC3 Q16853 6/20 0.43
TSHR P16473 2/20 0.43
CYP2C19 P33261 2/20 0.43
CHRM2 P08172 1/20 0.43
ADRA1A P35348 1/20 0.43
RGS12 O14924 1/20 0.43
GLA P06280 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840730 0.81 ADRA2C (0.46) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL30999496 0.81 TSHR (0.40) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL13458547 0.79 LMNA (0.50) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL9201789 0.79 KDM4E (0.56) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL2373415 0.79 ADRA2C (0.45) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL23221180 0.79 KDM4E (0.56) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL15450086 0.79 LMNA (0.50) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL3245155 0.79 KDM4E (0.56) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL8287058 0.79 KDM4E (0.56) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL11789068 0.77 KDM4E (0.54) ADRA2CKDM4EADRA2ALMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1790628-B1 METHOD FOR PRODUCING UNSATURATED VICINAL DIOL COMPOUND SUMITOMO CHEMICAL CO (JP) 2012-08-01 EP disclosed
US-7459588-B2 Method for producing unsaturated vicinal diol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-12-02 US disclosed
US-20080114185-A1 Method for Producing Unsaturated Vicinal Diol Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-05-15 US disclosed
EP-1790628-A1 METHOD FOR PRODUCING UNSATURATED VICINAL DIOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114185-A1 Method for Producing Unsaturated Vicinal Diol Compound CBR1, AKR1C3, CCNT2 ADRA2C 2723/4885KDM4E 4314/4885ADRA2A 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.